Table III.
Characteristics of primary breast diffuse large B-cell lymphoma patients with central nervous system relapse. None of the variables listed were significantly different between the two groups
Patients without CNS relapse N = 64 | Patients with CNS relapse N = 12 | |
---|---|---|
Stage IIE | 17 (27%) | 6 (50%) |
LDH Elevated | 7 (11%) | 2 (17%) |
Stage-modified IPI High (2-4) | 16 (25%) | 5 (42%) |
Rituximab given | 17 (27%) | 9 (75%) |
CNS prophylaxis given | 5 (8%) | 1 (8%) |
Abbreviations: CNS: Central Nervous System; IPI: International prognostic index; LDH: Lactate dehydrogenase.